Search Browse Earnings

Annexon, Inc. — SlamSEC

Annexon, Inc.

Nasdaq:ANNX

Pharmaceutical Preparations·BRISBANE, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$141.6M

FY 2024

Net Income

-$134.2M

FY 2024

EPS (Diluted)

-$1.77

FY 2024

Stock Price

$5.61

+8.5%

2026-03-09

52W Range

$1.28 – $7.18

P/E Ratio

-3.2x

Market Cap

$216.1M

Cash

$225.1M

FY 2024

Total Debt

—

Net Cash

$225.1M

Enterprise Value

-$9.0M

Debt / EBITDA

1.6x

FY 2024

EV / EBITDA

0.1x

Employees

—